OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Chronic Myelogenous Leukemia

Share this page  Facebook  Twitter  LinkedIn  Google+  Pinterest   Blogger
Chronic Myelogenous Leukemia

Chronic myelogenous leukemia is a rare type of cancer that the increased and uncontrolled growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood. Most of them people don’t know that they are infected with this kind of rare cancer and report shows that due to the smoking habits and exposure to high radiation for the time period.
Treatment of refractory chronic lymphocytic leukemia may include the following: Repeat treatment with monoclonal antibody therapy and combination chemotherapy. A clinical trial of chemotherapy with stem cell transplant. 

Chronic Myelogenous Leukemia

Major research on disease:
CLL patients are encouraged to explore clinical trials. Clinical trials test new drugs and treatments, many of which are being supported by LLS research programs, before they are approved by the FDA as standard treatment. Present ongoing present trend of clinical researched are follows Kinase Inhibitor Therapy, Monoclonal Antibody, Immunomodulatory Drug and Improvements in Stem Cell Transplantation.
Five-year relative survival was 68.7% overall in Germany,Survival is very less (at 67.5% vs 77.7% in Germany and the US, respectively and Survival increased between 2002 and 2006 by 12.0% points in Germany.


Expert PPTs

Speaker PPTs


High Impact List of Articles

Conference Proceedings